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Hepatitis C virus NS3 RNA helicase domain with a bound
oligonucleotide: the crystal structure provides insights into the
mode of unwinding
Joseph L Kim*, Kurt A Morgenstern, James P Griffith, Maureen D Dwyer, 
John A Thomson, Mark A Murcko, Chao Lin and Paul R Caron*
Background: Hepatitis C virus (HCV) represents a major health concern as it
is responsible for a significant number of hepatitis cases worldwide. Much
research has focused on the replicative enzymes of HCV as possible targets for
more effective therapeutic agents. HCV NS3 helicase may provide one such
suitable target. Helicases are enzymes which can unwind double-stranded
regions of DNA or RNA in an ATP-dependent reaction. The structures of several
helicases have been published but the structural details as to how ATP binding
and hydrolysis are coupled to DNA unwinding are unknown.
Results: The structure of the HCV NS3 RNA helicase domain complexed with
a single-stranded DNA oligonucleotide has been solved to 2.2 Å resolution. The
protein consists of three structural domains with the oligonucleotide lying in a
groove between the first two domains and the third. The first two domains have
an adenylate kinase like fold, including a phosphate-binding loop in the first
domain.
Conclusions: HCV NS3 helicase is a member of a superfamily of helicases,
termed superfamily II. Residues of NS3 helicase which are conserved among
superfamily II helicases line an interdomain cleft between the first two domains.
The oligonucleotide binds in an orthogonal binding site and contacts relatively
few conserved residues. There are no strong sequence-specific interactions
with the oligonucleotide bases.
Introduction
Infection by the hepatitis C virus (HCV) is responsible for
most transfusion-associated cases of non-A, non-B hepati-
tis and also accounts for a significant proportion of com-
munity-acquired hepatitis cases worldwide. Relatively few
HCV-infected individuals experience acute hepatitis, but
up to 85% appear to develop persistent infection that
often leads to chronic hepatitis and liver cirrhosis, eventu-
ally predisposing them to hepatocellular carcinoma. At
present, vaccines are unavailable and no broadly effective
therapies exist for this viral disease. Consequently, much
research has focused on the HCV replicative enzymes as
targets for more effective therapies.
HCV contains an approximately 9.6 kilo base (kb) single-
stranded positive sense RNA genome classified as its
own genus in the Flaviviridae family of animal viruses,
which also includes the flavivirus and pestivirus genera. Its
genome consists of a conserved 5′ nontranslated sequence
that serves as an internal ribosome entry site, a single open
reading frame that encodes a polyprotein of >3000 amino
acids, and a 3′ nontranslated region. The 3′ nontranslated
region contains tracts of poly(U)n and poly(UC)n followed
by a novel conserved 98 nucleotide sequence.
Proteolytic processing of the HCV polyprotein by virally-
encoded proteases generates several nonstructural (NS)
proteins with enzymatic activities essential for the replica-
tive cycle of the virus (reviewed in [1]). Examples of these
proteins include NS2 (which encodes a presumed metallo-
protease), NS5B (an RNA-dependent RNA polymerase),
and NS3 which is a bifunctional enzyme with a serine pro-
tease localized to the N-terminal 181 residues of the
protein and an RNA helicase located in the C-terminal
456 amino acids. The NS3 protease performs an intramol-
ecular cleavage at the junction between NS3 and NS4A to
form a tight noncovalent NS3–NS4A complex necessary
for efficient processing of the remaining polyprotein [2–4].
To date, no evidence exists to suggest that the serine pro-
tease and helicase domains are separated by proteolytic
processing of NS3 in vivo. This may reflect economical
packaging of these enzymatic components, or could belie
a functional interdependence between the two domains.
Numerous studies have demonstrated that the serine pro-
tease [5–7] and RNA helicase domains [8–11] of NS3 can
be expressed independently and isolated as catalytically
active species. Emerging evidence suggests, however, that
the NS3 protease and helicase domains may contact one
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another and modulate NS3 catalytic activities. For example,
apparent differences in the pH optima of ATPase and
RNA unwinding activities have been observed between a
contiguous NS3 protein complexed with the NS4A cofac-
tor [12,13] and an NS3 helicase domain [9–11,14]. Simi-
larly, the ATPase activities of both proteins differ in their
sensitivity to polynucleotide stimulation. Contiguous NS3
appears to have a lower apparent dissociation constant
for poly(U) than does the isolated helicase domain [8,
11,12,15]. Aside from these differences, both proteins
display nearly indistinguishable kinetic parameters for
NTP hydrolysis when stimulated with saturating poly-
nucleotide [8,12], both display 3´→5´ directionality for
translocation along a polynucleotide substrate, and the
helicases of both proteins effectively unwind duplex
RNA–RNA substrates [9,13].
In addition to HCV, all flaviviruses and pestiviruses
sequenced to date contain conserved helicase sequence
motifs in their homologous NS3 proteins, suggesting that
this enzyme plays an important role in the HCV replica-
tive cycle [16]. Consistent with this possibility, helicase
encoding sequences have been identified in other viruses
and helicases are suggested to catalyze the separation of
double-stranded nucleic acid structures during transcrip-
tion and genome replication (for review see [17]). Previous
studies with poliovirus, a positive-stranded RNA virus of
the Picornaviridae family, show that mutation of con-
served sequence motifs in the 2C helicase inhibits virus
replication and proliferation [18]. Similar mutational
studies on the helicases encoded by herpes simplex virus
type 1 and bovine papilloma virus also show that these
enzymes are critical for virus replication [19,20]. Recent
advances in the development of an infectious HCV cDNA
clone [21] should enable a direct test for the importance
and function of NS3 helicase activity in genome replica-
tion and virus infectivity.
Sequence-based classification has placed the HCV NS3
C-terminal domain into helicase superfamily II (SF-II),
along with nearly 100 proteins encoded by prokaryotic,
eukaryotic and viral genes. The SF-II helicases play criti-
cal roles in transcription, RNA processing, translation, and
RNA replication. Prototypical members of this family
include translation factor eIF-4A, DNA repair enzymes
UvrB, Rad-3 and Ercc-3, the human RNA processing
enzyme helicase A, and the vaccinia virus RNA helicase
NPH-II. All SF-II helicases contain seven highly con-
served motifs [22]. Based on mutational and crystallo-
graphic analyses these motifs have been implicated in
nucleotide triphosphate (NTP) binding, NTP hydrolysis,
and nucleic acid binding.
Despite elegant kinetic analysis of two related enzymes
from helicase superfamily I, helicase II (UvrD) and Rep,
members of, little is known about the details of how ATP
binding and hydrolysis leads to DNA or RNA strand
unwinding [23]. Two structures of helicases crystallized in
the absence of polynucleotide have been reported, but
unfortunately they have not yielded the critical information
needed to extrapolate to an enzyme mechanism [24,25].
We report here the structure of the HCV NS3 helicase
domain bound to single-stranded DNA at 2.2 Å resolution.
The location of the DNA in the structure is consistent
with that observed in the recently described 3.0 Å resolu-
tion structure of Rep DNA helicase complexed with a
single-stranded (ss) oligonucleotide [26]. The structure of
the HCV helicase, however, suggests that the mechanism
proposed by Korolev et al. [26] for Rep is not generally
applicable. Analysis of the structure of the HCV heli-
case–DNA complex leads to the proposal of a mechanism
of ATP-dependent DNA translocation that is consistent
with the enzymatic and structural properties of HCV, Rep,
and other helicases.
Results and discussion
Structure of HCV NS3 helicase
The structure of the HCV NS3 helicase (NS3 residues
189–626, corresponding to HCV polyprotein residues
1215–1652) complexed with a deoxyuridine octamer (dU8)
was determined by multiple isomorphous replacement
(MIR) combined with anomalous scattering. The protein
consists of three domains separated by a series of clefts
(Figure 1). Domains 1 and 3 share a more extensive inter-
face than either share with domain 2. This interface is
largely accounted for by packing of helices α5 and α6 from
domain 3 onto helix α4 from domain 1. As a result, the
clefts between domains 1 and 2 and domains 2 and 3 are
the largest. A previously published crystal structure of the
HCV NS3 helicase domain demonstrated that domain 2
could undergo rigid-body movements relative to domains
1 and 3 based on a comparison of two crystallographically
independent molecules [24]. Preliminary structural studies
on HCV helicase in a different crystal form also show a
rotation of domain 2 relative to the first and third, confirm-
ing that this domain is flexibly linked to the other two
(JPG and JLK, unpublished data). 
Domains 1 and 2 of the HCV helicase, which contain all
of the conserved helicase sequence motifs, have similar
topologies (Figure 2) and are also similar to domains 1A
and 2A of the four-domain PcrA and Rep DNA helicases
[25,26]. The structurally homologous domains of PcrA,
Rep, and HCV helicases each contain a parallel six-
stranded β sheet flanked by α helices. In addition, domain
1 of HCV helicase contains a seventh β strand running
antiparallel to the rest of the sheet. Superposition of
domains 1 and 2 yields a root mean square (rms) deviation
of 2.0 Å for 76 Cα atoms that form the core of each
domain. Domain 3 is predominantly α helical and is asso-
ciated with domain 2 by a pair of antiparallel β strands
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(Figure 1). An interesting component of domain 3 is a 40
amino acid region, preceding the C-terminal α helix, that
lacks secondary structure elements. This may represent a
flexible region of the protein that allows the C terminus of
NS3 to reach the active site of its own serine protease
domain to facilitate cleavage at the junction of NS3 and
NS4A during HCV polyprotein processing. This cleavage
is believed to occur in cis [27].
The N-terminal region of domain 1 contains a phosphate-
binding loop that is highly conserved among all helicases
and is commonly referred to as the ‘Walker A box’ or motif
I [28]. In the structure presented here, this loop contains a
bound sulfate ion (Figure 3a). This phosphate-binding
loop is structurally similar to those found in a number of
other ATPases [29]. The sulfate ion is stabilized by hydro-
gen bonds from the amide nitrogens of Gly207 and
Gly209, and the sidechains of Ser208, Lys210 and Ser211.
Lys210 makes an additional water-mediated contact to the
conserved Asp290 of the Asp-Glu-x-His (DExH) motif
(‘Walker motif B’ or motif II).
The sidechains of Asp290 and Glu291, the most conserved
residues in the DExH motif, point towards an open area
beneath the phosphate-binding loop that presumably is
occupied by Mg2+ and the γ-phosphate of the bound
Mg2+–NTP substrate. Cys292 is buried in the protein
interior while the His293 sidechain points into the cleft
between domains 1 and 2. The position of the sulfate in
this structure appears to be very similar to that of the β-
phosphate of ADP in the PcrA helicase–ADP complex
[25]. It is therefore likely that this sulfate ion occupies the
position which would be occupied by the β-phosphate
when NTP or nucleotide diphosphate (NDP) is bound to
the HCV helicase.
Highly conserved residues Gln460, Arg464 and Arg467
from domain 2 are solvent exposed in the interdomain
cleft, while Arg461 and Arg462 are buried in domain 2 and
stabilized by internal salt bridges and hydrogen bonds.
The position of Arg461 contrasts with that described in
the structure of the apo HCV NS3 helicase, which reported
this sidechain as being solvent exposed and interacting
with the phosphate backbone of single-stranded nucleic
acid modeled into this cleft [24].
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Figure 1
Figure 2
Superposition of domains 1 and 2. Domains 1 (blue) and 2 (red) were
superimposed based on conserved secondary structure motifs with a
2.0 Å Cα root mean square deviation over 78 residues. The result of
this superposition is the alignment of the sidechains of Thr269 and
Thr411, Ser231 and Ser370, and their bound nucleotides. The
locations of nucleotides 7 and 8 relative to the domain 1 core are
similar to the locations of nucleotides 3 and 4 relative to domain 2.
Residues corresponding to those binding to the 3′ end of the
oligonucleotide are depicted as thick lines. Also shown is the location
of Trp501 which stacks with the pyrimidine ring of nucleotide 8 in a
similar interaction to that observed between nucleotides 5 and 4.
Fold of HCV NS3 helicase domain complexed
with ssDNA. Stereo ribbon diagram illustrating
the overall fold of the NS3 helicase with
bound dU8. Domain 1 is colored blue, domain
2 red, and domain 3 green. The sulfate ion is
shown in light green and the DNA is colored
yellow.
Protein–ssDNA interactions
Studies of HCV NS3 helicase single-stranded nucleic
acid binding have demonstrated that poly(dU) binds to
the helicase with higher affinity than poly(rU) of the
same length [11]. Extrapolation of this data suggested
that a deoxyoligonucleotide 8-mer might be long enough
to bind to the helicase with high affinity and not inter-
fere with protein–protein contacts during crystallization.
Therefore, a dU8 oligonucleotide was used for crystalliza-
tion of the complex. In the structure presented here the
first two residues of the oligonucleotide are disordered
and have not been included in the model. The sugar–
phosphate backbone of the third nucleotide is well rep-
resented in electron-density maps (Figure 3b) while
density for the base is extremely weak. Electron density
for residues 4–8 is very well defined for the sugar–phos-
phate backbone and slightly weaker for the bases. Pre-
liminary studies with dU10 and dU12 oligonucleotides
show essentially the same electron density for the DNA,
and studies with longer oligonucleotides are under way
(JLK and KAM, unpublished data).
The bound ssDNA lies in a channel approximately 16 Å in
diameter that separates domain 3 from domains 1 and 2
(Figure 4). The 5′ end of the oligonucleotide resides at the
interface of domains 2 and 3 and its 3′ end is positioned at
the interface of domains 1 and 3. This orientation of the
DNA is roughly perpendicular to that of the ssRNA in a
model derived from the apo HCV helicase structure, in
which the ssRNA was placed in the cleft between domains
1 and 2 [24]. The binding site observed in this study is,
however, consistent with the oligonucleotide-binding site
in the Rep helicase–DNA structure [26].
Interactions between the ssDNA and enzyme are mostly
confined to the DNA backbone, as would be expected
for a nonspecific protein–nucleic acid complex, and are
concentrated at the two ends of the oligonucleotide.
Protein contacts emanate mostly from loops between
secondary structure elements in domains 1 and 2 (Figures
2 and 4). These contacts arise from symmetrically equiva-
lent residues in these two domains, so that protein con-
tacts to the dU4 and dU5 backbone phosphates are nearly
identical to those to the dU7 and dU8 phosphates. At the
3′ end of the DNA the dU8 phosphate is stabilized by a
hydrogen bond with Thr269 Oγ, which in turn accepts a
hydrogen bond from the mainchain NH of Lys272, and
by a hydrogen bond to the mainchain NH of Gly255.
Equivalent contacts to the dU5 phosphate are made by
the Arg393 mainchain NH and Thr411 Oγ, which accepts
a hydrogen bond from the Ala413 NH. The dU7 phos-
phate accepts a hydrogen bond from the Val232 NH and
interacts with the Ala233 NH and Ser231 Oγ via a bridg-
ing water molecule. The direct and water-mediated main-
chain interactions are duplicated by Lys371 and Lys372
from domain 2 to the dU4 phosphate. Ser370, the equiv-
alent residue in domain 2 to Ser231, makes a water-
mediated contact to the dU3 phosphate rather than dU4.
Superposition of domains 1 and 2 of HCV helicase reveals
that the residues involved in phosphate contacts are struc-
turally equivalent (Figure 2). This was an unanticipated
finding based on the poor sequence homology between
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Figure 3
Interactions with sulfate and DNA. (a) The phosphate-binding loop.
Residues surrounding the bound sulfate were superimposed on the
phosphate-binding loops of eight deoxynucleoside monophosphate
kinases (PDB accession codes 1AKE, 4AKE, 1DVR, 1KIN, 1DEK,
1GKY, 2ECK and 1UKD). (b) Electron density encompassing the
bound DNA substrate. The map shown in orange is the difference
Fourier (Fo–Fc) electron-density map calculated before DNA or water
molecules were built into the model. This map was calculated at 2.4 Å
and is contoured at 4.0σ. The map in blue is the final 2Fo–Fc electron-
density map calculated at 2.2 Å resolution using the refined model. The
map is contoured at 2.2σ.
these two domains. Additionally, the four residues inter-
acting with the phosphate backbone, Ser231, Thr269,
Ser370 and Thr411, are absolutely conserved in all HCV
NS3 sequences known to date. These findings suggest
that these two domains may have arisen from a gene
duplication event.
Residues dU4–dU8 are capped by interactions at each end
with hydrophobic sidechains. Trp501 stacks with the base
of dU8 while Val432 interacts with the dU4 base (Figure 4).
These two sidechains act as a pair of ‘bookends’, defining a
central binding cavity occupied by five nucleotides. Both
Val432 and Trp501 are highly conserved among HCV NS3
sequences but neither have been implicated in nucleic acid
binding or duplex unwinding. The Val432–dU4 base inter-
action induces significant rotation about the phosphate
backbone between dU3 and dU4 such that the bases are
completely unstacked (Figure 4). Stacking of Trp501 with
the dU8 base should similarly necessitate a large rotation
about the phosphate of the following nucleotide. The
resulting conformation of the DNA could be stabilized by
phosphate interactions with Arg253 and Lys272 (from
domain 1) and Lys372 and Lys373 (from domain 2), which
lie outside the central binding cavity.
Domain 2 contains a pair of extended antiparallel strands
encompassing residues 430–452, which are involved in
binding the 5′ end of the oligonucleotide (Figure 1). Two
other single-strand polynucleotide-binding proteins, single-
stranded binding protein (SSB) and tRNA synthetase,
contain antiparallel strands extending from their protein
core that are thought to make up the nucleic acid binding
site [30,31]. This region is termed the L45 loop in this
class of nucleic acid binding proteins. In the HCV NS3
helicase structure, the oligonucleotide binds in a channel
spanning two protein domains in a manner roughly similar
to that seen for replication protein A (RPA) [32]. In both
structures, the oligonucleotide is most tightly bound at the
3′ and 5′ ends making few contacts with the central
nucleotides. RPA also contains an L45 loop, which binds to
the 5′ end of the oligonucleotide.
The five nucleotides occupying the central binding cavity
of HCV NS3 helicase adopt a conformation reminiscent
of the central base pairs of DNA in the structures of
TATA box binding protein (TBP) in complex with the
TATA box [33,34]. In both instances the DNA is under-
wound considerably and the backbone smoothly bent,
compressing the edges of the bases. Comparison of the
DNA structure reported here with the central pyrimidine
stretch of the TATA box DNA reveals that the helicase-
bound DNA is more underwound than that seen in the
TBP–TATA box complex.
Our structure of the helicase–dU8 complex does not offer a
ready explanation as to why the enzyme binds to poly(dU)
with higher affinity than to other homopolymer DNAs [11].
Sequence-specific interactions with the DNA bases are not
observed within the central binding cavity of the helicase.
Differences in DNA binding affinity between different
sequences may, therefore, be a result of differences in ener-
getics of DNA distortion and base stacking rather than due
to base-specific hydrogen-bonding patterns.
Location of conserved sequence motifs
There is very high sequence conservation among various
HCV strains in the NS3 RNA helicase domain with >80%
sequence identity over the entire 456 amino acid poly-
peptide. The most highly conserved segments of these
domains correspond to the canonical helicase sequence
motifs (Figures 5 and 6a) [22]. In the three-dimensional
structure, residues from these motifs form the interface
between the first two domains (Figure 6b). Visual inspec-
tion of the structures of the PcrA DNA helicase from
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Figure 4
Protein–DNA interactions. View into the
central binding cleft of the NS3 helicase
domain. Residues dU4–dU8 lie in a cleft
formed by all three domains of the helicase.
Trp501 stacks nicely onto the base of dU8
while Val432 contacts the base of dU4. In
addition to the contacts mentioned in the text,
Arg393 hydrogen bonds to the phosphate of
dU6. Atoms are shown in standard colors; the
DNA is drawn in thick lines and the DNA
bases are numbered in yellow. 
Bacillus stearothermophilus [25] and Escherichia coli Rep
DNA helicase [26] (coordinates not available) suggests
overall structural similarity between domains 1A and 2A of
these DNA helicases and domains 1 and 2 of the HCV
helicase. The locations of the conserved DNA helicase
sequence motifs overlap with those of the HCV helicase
allowing an unambiguous alignment of these motifs.
Mutagenesis of individual residues within these motifs in
HCV helicase, or in other RNA helicases, has demon-
strated that they are essential for enzyme activity. The
individual phenotypes of these mutants can now be more
fully explained using the enzyme structure.
Domain 1 of the HCV helicase has a fold similar to that
found in a number of ATP transphosphorylases, such as
adenylate and thymidine kinases. In particular, the phos-
phate-binding loop formed by motif I (Gly-Ser-Gly-Lys-
Thr; GSGKT) is virtually identical to the corresponding
loop in the kinases. In these kinases this loop is involved
in binding the β-phosphate of ATP. HCV helicase has a
sulfate bound in this exact location (Figure 3a). Mutation
of residues corresponding to the lysine residue of HCV
helicase motif I (Lys210) in other helicases invariably
leads to inactivation [35,36]. Motif II (DExH) is proximal
to the GSGKT phosphate-binding loop and is expected
to be involved in binding the Mg2+–ATP substrate. In
adenylate and thymidine kinases, a conserved aspartate
binds Mg2+, which helps orient the ATP for nucleophilic
attack [37,38]. Mutation of the equivalent aspartate residue
in these kinases, or in other helicases, inactivates ATP
hydrolysis [37,39–41]. His293 is located at the bottom of
the interdomain cleft and approximately 4 Å away from
Val456 and Gln460. This histidine appears to be essen-
tial for coupling the ATPase activity to polynucleotide
binding; mutations of this histidine in HCV NS3 and
vaccinia NPH-II helicases result in a functional ATPase
with no helicase activity [39,42]. Unfortunately, the
structure presented here does not provide an obvious
explanation as to how this residue couples the ATPase
and unwinding activities.
Studies in several helicases have looked at the effects
of mutations in motif VI (Gln-Arg-x-Gly-Arg-x-Gly-Arg;
QRxGRxGR), yet a role for this motif has not been clearly
defined. In the HCV helicase, residues in this motif are
located in the cleft between domains 1 and 2. Gln460 lies
at the bottom of the cleft opposite from His293. Mutation
of the corresponding glutamine in vaccinia virus helicase
and in eIF-4A leads to significant decreases in ATPase
activity [41,43]. There are three conserved arginines in
motif VI that were proposed by Yao et al. [24] to be
involved in binding ssRNA in the cleft between domains
1 and 2 of the HCV helicase. Our structure of the heli-
case–dU8 complex demonstrates that this interpretation is
unlikely to be correct. In this structure, Arg461 points
away from the cleft and is hydrogen bonded to Asp412
and Asp427. Mutation of this residue in a vaccinia virus
helicase leads to decreases in RNA binding [43], possibly
as a consequence of alterations in the conformation of
Asp412 which lines the polynucleotide-binding channel.
Arg464 and Arg467 extend into the interdomain cleft,
directly across from the presumed locations of the γ- and
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Figure 5
The primary and secondary structure of HCV
NS3 helicase. The secondary structure is
indicated above the sequence, and the
conserved sequence motifs are underlined.
The non-HCV N-terminal and C-terminal
residues, which were added during cloning,
are depicted in lower case letters. No density
was observed for residues in italics. The
residues are numbered based on their
location in the NS3 protein.
β1
 
                               α1
       ←→    ←→
         .         .         .         .         .         .
     mVDFIPVENLETTMRSPVFTDNSSPPAVPQSFQVAHLHAPTGSGKSTKVPAAYAA  220
            β2
 
                       α2
 
                            β3
 
         β4
 
            β5
 
        α3
   ←→    ←→        ←→    ←→      ←→  ←→




               β6                               α4              α4Α          β7                                        β1'
      ←→                ←→ ↔      ←→                                 ←→
         .         .         .         .         .         .
GGAYDIIICDECHSTDATSILGIGTVLDQAETAGARLVVLATATPPGSVTVPHPNIEEVA  340
               β1Α'  β1Β'     α1'            β2'                      α2'                     β3'
                ↔      ↔     ↔        ←→       ←→           ←→
         .         .         .         .         .         .
LSTTGEIPFYGKAIPLEVIKGGRHLIFCHSKKKCDELAAKLVALGINAVAYYRGLDVSVI  400
                β5'                                  β6'             β6Α'                      β6Β'                  α4'
           ←→                                         ←→         ←→                 ←→          ←
         .         .         .         .         .         .
PTSGDVVVV  ATDAL   MTG   FTGDFD  SVIDCNTCVTQTVDFSLDPTFTIETTTLPQDA  VSRTQ   460
                           β7'                       β8                 α5                                   α6
→                   ←→                    ↔      ←→                  ←→
         .         .         .         .         .         .
  RRGRTGRG  KPGIYRFVAPGERPSGMFDSSVLCECYDAGCAWYELTPAETTVRLRAYMNTP  520
        β9                α7                             α8                                  α9
   ↔      ←→            ←→   ←→ 
         .         .         .         .         .         .
GLPVCQDHLEFWEGVFTGLTHIDAHFLSQTKQSGENFPYLVAYQATVCARAQAPPPSWDQ  580
                                                                                     α10
                                    ←→   
         .         .         .         .         .         .
MWKCLIRLKPTLHGPTPLLYRLGAVQNEVTLTHPITKYIMTCMSADLEVVTgsgshhhhhh 641
Structure
α-phosphates of ATP. These residues appear to be
poised to contact the ATP phosphates upon closure of
this interdomain cleft. This role would be similar to the
function of conserved basic residues in the second domain
of adenylate kinase. Consistent with the possibility that
Arg464 and Arg467 are directly involved in ATP binding,
mutations of the corresponding residues to alanine or
glutamine in vaccinia NPH-II or eIF-4A reduce the
ATPase activity to <20% of wild type levels [43,44].
Arg467 appears to be conserved among all three helicase
superfamilies (Figure 6a) [22].
Motif III connects domains 1 and 2, and appears to be a
flexible linker [24]. Motif Ia forms part of the β-sheet core
of domain 1, but also extends to the oligonucleotide.
Residues in motif V both contact the oligonucleotide and
line the interface between the first two domains. In partic-
ular, Thr411 makes a hydrogen bond to the phosphate of
dU3 of the oligonucleotide.
The current structure lacks any region corresponding to
motif IV in the Rep and PcrA helicases [25,26], members
of the superfamily I class of helicases. Previous sequence
alignments that found similarities between motif IV of
superfamily I and II helicases were done with rather weak
criteria and may not have been significant. In the DNA
helicases, motif IV is responsible for binding the adenine
ring of ATP [25,26]. Mutation of a conserved arginine in
this motif in UvrD increases the Km for ATP by 37-fold
[45]. In HCV helicase, either another protein segment
which is not visible in the current structure substitutes for
motif IV or the adenosine ring binds elsewhere. Residues
from the putative motif IV in HCV helicase include
Ser370 and Lys371, which contact the DNA via a water-
mediated hydrogen bond and a backbone interaction,
respectively. Therefore, sequences corresponding to motif
IV in superfamily I and superfamily II helicases occupy
different regions and appear to have different functions.
We suggest that a new motif, designated IVa, be used to
describe residues corresponding to the putative HCV
helicase motif IV. In E. coli UvrD, motif IVa may corre-
spond to the sequence Arg-Ser-Asn-Ala-Gln-Ser-Arg-Val-
Leu (residues 355–363).
Proposed domain closure and translocation
In HCV helicase, conserved basic residues from motif VI
are positioned across the interdomain cleft from the
expected location of the ATP γ-phosphate. A very similar
situation is observed in the structures of the adenylate
kinases, where basic residues lie across a cleft from the
ATP-binding site. Binding of ATP (or ATP analogs) to
these kinases leads to a conformational change in the
enzyme, resulting in the burial of previously solvent-
exposed phosphates [46]. Mutation of these conserved
basic residues in adenylate kinase results in an ‘open’
structure with poor catalytic activity [47].
We propose that an analogous closure occurs between
domains 1 and 2 of HCV helicase upon ATP binding. This
closure could be driven by interaction of basic residues in
motif VI with the ATP phosphates (Figure 7). Sequence
and structural conservation of these basic residues in motif
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Figure 6
                I              Ia           II            III
NS3    204 APTGSGKSTK(13)VLNPSVAATLGF( 40)DECHSTD(25)TATPPGSVTVPHPN
NPH-II 185 GGTGVGKTSQ(28)VILSLPRIALVR( 60)DEVHEHD(23)TATLEDDRERLKVF
eIF-4A  63 AQSGTGKTGT(19)MLAPTRELALQI( 63)DEADEML(24)SATMPNDVLEVTTK
PcrA    31 AGAGSGKTRV(20)AITFTNKAAREM(150)DEYQDTN(19)VGDADQSIYRWRGA
UvrD    30 AGAGSGKTRV(20)AVTFTNKAAREM(150)DEFQDTN(19)VGDDDQSIYGWRGA
Rep     22 AGAGSGKTRV(20)AVTFTNKAAAEM(150)DEYQDTN(19)VGDDDQSIYSWRGA

              IV?             V                 VI
NS3    365 LIFCHSKKK( 36)ATDALMTGFTGDFD(32)VSRTQRRGRTGRG
NPH-II 397 IVFVASVAQ( 43)STPYLESSVTIRNV(24)SMRDQRKGRVGRV
eIF-4A 263 VIFCNTRRK( 43)STDLLARGIDVQQV(12)ENYIHRIGRGGRF
PcrA   280 ILLEQNYRS(273)MTLHAAKGLEFPVV(23)EERRLAYVGITRA
UvrD   278 IRLEQNYRS(271)MTLHSAKGLEFPQV(23)EERRLAYVGVTRA




Conserved motifs. (a) Sequence motifs in other helicases. Sequences
of conserved motifs from other helicases discussed in the text are
aligned. HCV NS3 (this study), NPH-II (vaccinia virus, SwissProt
VI08_VACCV) and eIF-4A (SwissProt IF4A_YEAST) are members of
superfamily II; PcrA [25], UvrD (helicase II, SwissProt UVRD_ECOLI)
and Rep (SwissProt REP_ECOLI) are from superfamily I. To aid
comparison of the structures of enzymes from superfamilies I and II, the
motifs are colored in a similar manner to that used in the previous
report of the PcrA helicase structure [25]. The numbers on the left of
each line denote the residue number of the first residue shown. The
numbers in parentheses indicate the number of residues not shown.
(b) Location of conserved motifs. Conserved sequence motifs are
located at the interface between domains 1 and 2; they are colored as
in (a). The sulfate ion is shown in yellow.
VI among superfamily I and II helicases suggests that
domain closure upon ATP binding is a general feature of
these enzymes.
Gln460 and His293, from motifs VI and II respectively, lie
on opposite sides of the interdomain cleft and possibly
serve as ‘gatekeepers’, altering the equilibrium between
the ‘open’ and ‘closed’ forms based on the binding of
polynucleotide. Potential interaction of residues in these
positions was predicted by the observation that helicases
with the DExH motif II sequence usually contain a gluta-
mine in motif VI, whereas those with a DEAD sequence
contain a histidine [22].
There is structural evidence that the linkage of the second
domain in HCV helicase to the rest of the protein is flexi-
ble. In the HCV helicase structure reported by Yao et al.
[24] the differences between the two molecules in the
asymmetric unit can be attributed to a rotation of domain
2 by a few degrees. The relatively minor movement of
domain 2 observed in their structures [24] probably
reflects changes in the local environment in the crystals.
We propose a much more substantial conformational
change would occur when the enzyme binds ATP or suit-
able analog. Direct confirmation of the flexibility of this
domain needs to be addressed and preliminary crystallo-
graphic results indicate that there are significant move-
ments of this domain in different crystal forms (JLK and
JPG, unpublished results). A conformational change could
explain the observed two-stage kinetics of ATP binding to
Rep, where rapid initial binding is followed by a much
slower step leading to tighter binding [48]. Evidence for
conformational changes has been observed for Rep and
helicase II based on alterations in protease sensitivity
upon nucleotide binding [49]. Binding of ATP to PcrA
helicase has also been proposed to lead to a conforma-
tional change of the enzyme [25].
Large conformational changes in a DNA metabolizing
enzyme are not unique, as they have been seen in the
structures of mRNA capping enzyme in the presence of
GTP [50]. In these structures, the guanosine nucleotide is
bound to the N-terminal domain with the phosphates
located near the interface with the C-terminal domain. In
the open conformation these domains are separated by a
10–13 Å cleft. Several residues which are highly conserved
among mRNA capping enzymes are located in the C-ter-
minal domain, including Arg295 and Arg298. In the closed
conformation, these residues are relocated by approxi-
mately 10 Å and are bound to the GTP β- and γ-phos-
phates. Closures of large interdomain clefts have also been
proposed in the structurally homologous ATP-dependent
DNA ligases, one structure of which has been solved in
the open conformation [51].
Domain 2 of HCV helicase also interacts with the single-
stranded polynucleotide. One could envision that move-
ment of this domain results in concomitant movement of
the nucleic acid substrate relative to the protein. Interac-
tions between residues in domain 2, such as Val432 and
Thr448, and the bases at the 5′ end of the single-stranded
nucleic acid binding site would lead to translocation of the
polynucleotide in the 5′ to 3′ direction as domain 2 closes
(Figure 7). Trp501 in domain 3 stacks with a base near the
3′ end of the single-stranded oligonucleotide and disrupts
stacking with neighboring bases. Closure of the inter-
domain cleft would force several bases to slip past Trp501.
Hydrolysis of ATP would then result in opening of the
























































Helicase mechanism schematic. The binding of polynucleotide by NS3
helicase in the absence of ATP leaves a large cleft between domains 1
and 2. Binding of ATP occurs with the β-phosphate binding to
residues in motif I (GSGKT) and the γ-phosphate with Mg2+ binding to
the conserved acidic residues in motif II (DECH). This results in the
closing of the interdomain cleft and the binding of conserved arginines
in motif VI (QRRGRTGR) to the ATP phosphates. Val432 and Trp501
disrupt base stacking at either end of the single-stranded region.
Closure of the interdomain cleft leads to translocation of the single
strand in the 5′ to 3′ direction and forces several bases to slip past
Trp501. Hydrolysis of ATP facilitates opening of the cleft and release
of ADP. The orientation of Trp501 favors movement of the
polynucleotide in only one direction such that opening of the gap
results in net movement of the helicase in a 3′→5′ direction.
cleft and release of ADP. The orientation of Trp501 favors
movement of the polynucleotide in only the 5′ to 3′ direc-
tion, such that opening of the cleft results in net move-
ment of domain 2 in a 3′ to 5′ direction. By this mechanism
the translocation reaction of the helicase resembles a
ratchet. A general ratchet-like mechanism has been pro-
posed for the RecB helicase based on conformational
changes observed by protease mapping [52]. 
The proposed model suggests that a single ATP hydrolysis
event can result in protein translocation along several
bases of a polynucleotide. Studies with the UvrD DNA
helicase have demonstrated that the enzyme is capable of
translocating more than one base per reaction cycle [53],
although the number of ATP hydrolysis events per
observed reaction cycle was unknown in this experiment.
Our model is consistent with predictions that helicases
need not actively unwind the double-stranded substrate,
but can function by capturing the single-stranded regions
which arise due to thermal fluctuations at the fork [54].
The translocation process proposed here would thus be
considered an active process while the melting of the
double-stranded structure at the fork would be passive.
The mechanism which we propose is substantially differ-
ent from the active rolling mechanism described for the
Rep helicase by Wong and Lohman [55] and recently
advanced in a paper describing the 3.0 and 3.2 Å structures
of Rep bound to ssDNA [26]. As we previously noted,
there is overall structural similarity between domains 1 and
2 of HCV helicase and domains 1A and 2A of Rep. Impor-
tant to our proposed mechanism, these two domains
contain all the motifs conserved among DNA/RNA heli-
case sequences listed in Figure 6a. In HCV helicase,
however, there is no structural equivalent of Rep domain
2B, which has been proposed to have a critical role in the
active rolling mechanism [26].
Biological implications
Infection by hepatitis C virus (HCV) is responsible for
many cases of community-acquired hepatitis world-
wide, and therefore represents a serious health concern.
At present, no vaccine is available for this virus and
recent research has been aimed at finding more effec-
tive therapies. Much of this work has focused on the
HCV replicative enzymes, as these may provide suit-
able targets for new therapeutic leads. One such enzyme
which may prove important in this respect is the HVC
RNA helicase.
The RNA helicase encoded by the HCV NS3 gene is a
member of a very broad superfamily of RNA and DNA
helicases. In this study, the X-ray crystal structure of the
HCV NS3 helicase complexed with a single-stranded (ss)
DNA oligonucleotide has been determined at 2.2 Å reso-
lution. The structure elucidates both the location and
polarity of the single-stranded nucleic acid binding site for
this and other superfamily II helicases. Domains 1 and 2
of this three-domain enzyme are structurally similar and
make symmetrically equivalent interactions with the
backbone of the bound nucleic acid. These two domains
also contain all of the conserved sequence motifs common
to helicases, as well as the NTP-binding site. The struc-
ture of the HCV helicase–ssDNA complex suggests a
number of structural and biochemical experiments which
can be designed to help elucidate the mechanism of




The HCV NS3 RNA helicase domain (the C-terminal 465 amino acids
of the 631-residue NS3 protein) was subcloned from a cDNA of the
HCV H strain [56,57] into a pET expression vector. The resulting
plasmid, pET-BS(+)/HCV/NS3-C465-His, also contains a six-histi-
dine tag fused to the C terminus of the NS3 helicase domain to facili-
tate protein purification. In addition, amino acid changes have been
introduced at four residues in the helicase domain by site-directed
mutagenesis, according to the consensus sequence of the HCV
genotype 1 (CL, unpublished data); these changes are Ser332→Pro,
Asn403→Ser, Ser410→Ala and Met505→Thr. E. coli BL21(DE3)
cells, freshly transformed with the pET-BS(+)/HCV/NS3-C465-His
plasmid, were grown at 30°C in luria broth (LB) media supplemented
with 50 µg/ml of carbenicillin. When the density reached an OD600 of
1.0, the cells were induced for 3 h at 30°C by the addition of iso-
propyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of
0.8 mM. After induction, the cells were harvested and stored frozen
at –70°C until purification.
Purification of the NS3 helicase domain
The NS3 helicase domain was purified from the soluble fraction of
recombinant E. coli lysates; all procedures were performed at 4°C. Cell
paste (100–150 g) was suspended in 15 volumes of 50 mM HEPES
(pH 8), 0.3 M NaCl, 2.5 mM β-mercaptoethanol, 0.1 mM phenylmethyl-
sulfonyl fluoride (PMSF). Cells were ruptured using a microfluidizer and
the resulting homogenate was clarified by centrifugation at 100,000 ×
g for 40 min. The supernatant was initially fractionated by ammonium
sulfate precipitation, as described [11]. The final precipitate was col-
lected by centrifugation at 40,000 × g for 20 min and suspended in
400 ml of 50 mM HEPES (pH 8), 5 mM β-mercaptoethanol by applying
5–10 strokes of a dounce homogenizer. This solution was again clari-
fied by centrifugation at 100,000 × g for 20 min. The supernatant was
brought to 50 mM HEPES, (pH 8), 0.3 M NaCl, 25% glycerol, 2.5 mM
β-mercaptoethanol (equilibration buffer), 5 mM imidazole (pH 8) was
added, and the protein solution was incubated overnight with 7 ml of
Ni-agarose resin. The resin was collected by centrifugation at 600 × g
for 5 min and packed into a Pharmacia XK 16 column equipped with
two flow adapters. The resin was washed in two steps at 1.5 ml/min
with 15 volumes of equilibration buffer containing 5 mM and 15 mM
imidazole, and eluted at 0.5 ml/min with 80 mM imidazole. The eluant
was diluted to 2.5 mM imidazole with equilibration buffer and incubated
with 3 ml of Talon resin. The resin was again collected by low speed
centrifugation and packed into a Pharmacia XK 16 column, as
described. The resin was washed stepwise at 1.0 ml/min with ten
column volumes of equilibration buffer containing 5 mM and 7 mM imi-
dazole. The column was eluted at 0.3 ml/min with equilibration buffer,
60 mM imidazole. Eluants were then size-fractionated at 0.5 ml/min on
a Pharmacia Superdex 75 HR 16/60 column in series connected to a
BioCad chromatography system, and previously equilibrated with
25 mM HEPES (pH 8), 0.3 M NaCl, 1% glycerol, 2.5 mM β-mercap-
toethanol. The protein (0.1–0.15 mg/g paste) eluted as a monomer of
~54 kDa that was judged to be greater than 98% pure by sodium
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dodecyl sulfate polyacrylamide gel electrophoresis and Coomassie R-
250 staining. The protein was concentrated to 10 mg/ml by ultrafiltra-
tion and slowly diluted with five volumes of 15 mM MES (pH 6.5),
2.5 mM β-mercaptoethanol and again concentrated to 10 mg/ml. The
dilution step was repeated with two volumes of buffer and concen-
trated to 13 mg/ml. Oligonucleotide (dU8) was then added to yield a
1:1 molar ratio of protein and the nucleic acid. The dU8 was purchased
from Oligo Therapeutics, Inc..
The NS3 helicase domain ATPase specific activity was estimated at
25°C using 10 nM enzyme in a continuous spectrophotometric assay
that couples ATP hydrolysis to NADH oxidation [8,11]. The ATPase
specific activity was stimulated 10- to 12-fold upon addition of 0.12 mM
poly rU (Pharmacia Biotech) to yield an activity level of ~17 nmoles/
ADP/s/nM enzyme. Protein concentration was estimated by UV
absorption spectroscopy at 280 nm using a molar extinction coefficient
of 64,000 M–1 cm–1 [11]. Nucleic acid concentrations were determined
by UV absorption spectroscopy at 260 nm using extinction coefficients
provided by the manufacturer.
Helicase activity
BsrBI-digested plasmid pSP65 (Promega) was transcribed with SP6
polymerase to produce a 98-nucleotide template strand. BamHI-
digested pSP64 (Promega) was transcribed with SP6 polymerase in
the presence of [α-32P-UTP] to generate the radioactive 34-nucleotide
release strand. The RNAs were treated with DNase, extracted with
phenol-chloroform, and precipitated with ethanol. The RNA–RNA sub-
strate was generated by annealing the two RNA transcripts and gel
purified as described [58]. For the RNA–DNA substrate, the 98-
nucleotide template strand RNA was transcribed in the presence of [α-
32P-UTP]. A 34-nucleotide DNA oligonucleotide was synthesized with
a sequence corresponding to the deoxynucleotide version of the RNA
release strand described above. The RNA–DNA substrate was similarly
prepared and standard helicase reactions were carried out [58]. The
unwinding efficiency of RNA–RNA substrate by the HCV NS3 helicase
domain is comparable to that reported previously [9,10].
Crystallization and data collection
Crystals of the NS3 helicase–dU8 complex were grown by hanging
drop vapor diffusion over wells containing 0.1 M Tris pH 8.0, 0.2 M
Li2SO4, 18% polyethylene glycol 6000, and 8 mM β-mercaptoethanol.
Drops were macroseeded within 12 h after being set up. Crystals grew
over the course of 2–3 weeks to dimensions of 0.4 × 0.4 × 0.1 mm3.
The crystals belong to space group P21212 with unit cell dimensions
a = 73.1 Å, b = 117.5 Å, c = 63.4 Å, and contain one helicase–dU8
complex per asymmetric unit.
Statistics for data collection, heavy-atom refinement, and crystallo-
graphic refinement are given in Table 1. Heavy atom soaks were
carried out by transferring crystals to a solution containing 0.1 M Tris
pH 8.0, 0.2 M Li2SO4, 17% polyethylene glycol 6000, 8 mM β-mercap-
toethanol, in addition to the heavy atom in question. Heavy-atom soaks
with K2WO4 were performed in the absence of Li2SO4. Crystals were
transferred to a solution containing 0.08 M Tris pH 8.0, 0.2 M Li2SO4,
16% polyethylene glycol 6000, 8 mM β-mercaptoethanol, and 15%
glycerol and immediately frozen in a dry nitrogen gas stream at 100K
(Molecular Structure Corp., Houston, TX) for data collection. Data was
acquired by oscillation photography on a Rigaku R-AXIS IIC phosphor
imaging area detector mounted on a Rigaku RU200 rotating-anode
generator (MSC), operating at 50 kV and 100 mA. Measured intensi-
ties were integrated, scaled, and merged using the HKL software
package (Z Otwinowski and W Minor).
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Table 1
Crystallographic data collection and refinement.
Data set* Native Me3PbOAc Me3PbOAc Me3PbOAc Me3PbOAc K2PtCl4 K2PtCl4 K2WO4
K2WO4 K2WO4
iso anom iso anom iso anom iso
Resolution (Å) 2.1 2.2 2.2 2.2 2.2
Unique reflections 31,255 28,076 25,626 26,516 28,501
Redundancy 3.2 3.3 2.6 2.3 3.3
Completeness (%) 96 99 90 93 95
Rsym (%)† 4.1 4.9 4.2 4.3 4.2
MIR analysis
Resolution (Å) 2.3 2.3 2.7 2.3 3.2 6.0 6.0 6.5
Riso/Rano (%)‡ 8.6 2.5 7.5 3.2 7.9 2.9 7.8
Number of sites 2 2 1 2 2 2 1
Phasing power§ 1.77 1.54 1.79 1.35 0.95 0.70 0.86
Rcullis 0.64 0.64 0.66 0.68
Refinement statistics
Resolution (Å)# 3.71 3.08 2.73 2.50 2.33 2.20 Total
R factor (%) 19.1 21.9 24.7 26.1 27.6 28.2 22.8
Rfree (%)¶ 26.8 26.9 30.2 31.3 31.5 31.6 28.7
Reflections (F > 2.0σF) 4076 4081 3982 3916 3774 3628 25,780
Nonhydrogen atoms 3491
Rms bond lengths (Å) 0.007
Rms bond angles (°) 1.41
*For the derivatives, iso = the isomorphous data set and anom = the
anomalous data set. †Rsym = Σ|I– < I >|/ΣI, where I is the observed
intensity and < I > is the average intensity obtained from multiple
observations of symmetry-related reflections. ‡Riso = Σ ||FPH–|FP||/Σ|FP|,
where |FP| is the protein structure-factor amplitude and |FPH| is the
heavy-atom derivative structure-factor amplitude. §Phasing power = the
root mean square (rms) (|FH|/E), where |FH| is the heavy atom
structure-factor amplitude and E is the residual lack of closure. #Low
resolution cut-off 6.0 Å. ¶The free R value was calculated using 9% of
the data.
Phasing, model building and refinement
Heavy-atom positions were located from difference Patterson and
anomalous difference Patterson maps and confirmed with difference
Fourier syntheses. Heavy-atom parameters were refined and phases
computed to 2.3 Å using the program PHASES [59]. MIR phases were
improved by cycles of solvent flattening [60] combined with histogram
matching [61] using the CCP4 crystallographic package [62]. Model
building was carried out using QUANTA96 (Molecular Simulations),
and all refinement was done in XPLOR [63], using the free R value [64]
to monitor the course of refinement. The current model, refined using
data from 6.0–2.2 Å, consists of NS3 helicase residues 190–414 and
418–626, residues 3–8 of dU8, one bound sulfate ion, and 159 well
ordered water molecules.
Accession numbers
The coordinates of the HVC NS3—dU8 complex have been deposited
in the PDB with accession code 1A1V. 
Acknowledgements
We would like to thank Michael Sintchak, Michael Su and Keith Wilson for
helpful discussions. We would also like to thank Vicki Sato for valuable
comments on the manuscript.
References
1. Neddermann, P., Tomei, L., Steinkuhler, C., Gallinari, P., Tramontano,
A. & De Francesco, R. (1997). The nonstructural proteins of the
hepatitis C virus: structure and functions. Biol. Chem. 378, 469–476.
2. Failla, C., Tomei, L. & De Francesco, R. (1995). An amino-terminal
domain of the hepatitis C virus NS3 protease is essential for
interaction with NS4A. J. Virol. 69, 1769–1777.
3. Bartenschlager, R., Lohmann, V., Wilkinson, T. & Koch, J.O. (1995).
Complex formation between the NS3 serine-type proteinase of the
hepatitis C virus and NS4A and its importance for polyprotein
maturation. J. Virol. 69, 7519–7528.
4. Tanji, Y., Hijikata, M., Satoh, S., Kaneko, T. & Shimotohno, K. (1995).
Hepatitis C virus-encoded nonstructural protein NS4A has versatile
functions in viral protein processing. J. Virol. 69, 1575–1581.
5. Kim, J.L., et al., & Thomson, J.A. (1996). Crystal structure of the
hepatitis C virus NS3 protease domain complexed with a synthetic
NS4A cofactor peptide. Cell 87, 343–355. 
6. Markland, W., et al., & Chambers, S.P. (1997). Purification and
characterization of the NS3 serine protease domain of hepatitis C virus
expressed in Saccharomyces cerevisiae. J. Gen. Virol. 78, 39–43.
7. Steinkuhler, C., et al., & De Francesco, R. (1996). Activity of purified
hepatitis C virus protease NS3 on peptide substrates. J. Virol. 70,
6694–6700.
8. Suzich, J.A., et al., & Collett, M.S. (1993). Hepatitis C virus NS3
protein polynucleotide-stimulated nucleoside triphosphatase and
comparison with the related pestivirus and flavivirus enzymes. J. Virol.
67, 6152–6158.
9. Tai, C.L., Chi, W.K., Chen, D.S. & Hwang, L.H. (1996). The helicase
activity associated with hepatitis C virus nonstructural protein 3
(NS3). J. Virol. 70, 8477–8484.
10. Jin, L. & Peterson, D.L. (1995). Expression, isolation, and
characterization of the hepatitis C virus ATPase/RNA helicase. Arch.
Biochem. Biophys. 323, 47–53.
11. Preugschat, F., Averett, D.R., Clarke, B.E. & Porter, D.J.T. (1996). A
steady-state and pre-steady-state kinetic analysis of the NTPase
activity associated with the hepatitis C virus NS3 helicase domain. 
J. Biol. Chem. 271, 24449–24457.
12. Morgenstern, K.A., et al., & Thomson, J.A. (1997). Polynucleotide
modulation of the protease, nucleoside triphosphatase, and helicase
activities of a hepatitis C virus NS3–NS4A complex isolated from
transfected COS cells. J. Virol. 71, 3767–3775.
13. Hong, Z., et al., & Kwong, A.D. (1996). Enzymatic characterization of
hepatitis C virus NS3/4A complexes expressed in mammalian cells by
using the herpes simplex virus amplicon system. J. Virol. 70,
4261–4268.
14. Gwack, Y., Kim, D.W., Han, J.H. & Choe, J. (1996). Characterization of
RNA binding activity and RNA helicase activity of the hepatitis C virus
NS3 protein. Biochem. Biophys. Res. Commun. 225, 654–659.
15. Kanai, A., Tanabe, K. & Kohara, M. (1995). Poly(U) binding activity of
hepatitis C virus NS3 protein, a putative RNA helicase. FEBS Lett.
376, 221–224.
16. Miller, R.H. & Purcell, R.H. (1990). Hepatitis C virus shares amino acid
sequence similarity with pestiviruses and flaviviruses as well as
members of two plant virus supergroups. Proc. Natl. Acad. Sci. USA
87, 2057–2061.
17. Kadare, G. & Haenni, A.L. (1997). Virus-encoded RNA helicases. 
J. Virol. 71, 2583–2590.
18. Mirzayan, C. & Wimmer, E. (1992). Genetic analysis of an NTP-
binding motif in poliovirus polypeptide 2C. Virology 189, 547–555.
19. MacPherson, P., Thorner, L., Parker, L.M. & Botchan, M. (1994). The
bovine papilloma virus E1 protein has ATPase activity essential to viral
DNA replication and efficient transformation in cells. Virology 204,
403–408.
20. Martinez, R., Shao, L. & Weller, S.K. (1992). The conserved helicase
motifs of the herpes simplex virus type 1 origin-binding protein UL9
are important for function. J. Virol. 66, 6735–6746.
21. Kolykhalov, A.A., Agapov, E.V., Blight, K.J., Mihalik, K., Feinstone, S.M.
& Rice, C.M. (1997). Transmission of hepatitis C by intrahepatic
inoculation with transcribed RNA. Science 277, 570–574.
22. Gorbalenya, A. & Koonin, E.V. (1993). Helicases: amino acid
sequence comparisons and structure-function relationships. Curr.
Opin. Struct. Biol. 3, 419–429.
23. Lohman, T.M. & Bjornson, K.P. (1996). Mechanisms of helicase-
catalyzed DNA unwinding. Annu. Rev. Biochem. 65, 169–214.
24. Yao, N., Hesson, T., Cable, M., Hong, Z., Kwong, A.D., Le, H.V. &
Weber, P.C. (1997). Structure of the hepatitis C virus RNA helicase
domain. Nat. Struct. Biol. 4, 463–467.
25. Subramanya, H.S., Bird, L.E., Brannigan, J.A. & Wigley, D.B. (1996).
Crystal structure of a DExx box DNA helicase. Nature 384, 379–383.
26. Korolev, S., Hsieh, J., Gauss, G.H., Lohman, T.M. & Waksman, G.
(1997). Major domain swiveling revealed by the crystal structures of
complexes of E. coli Rep helicase bound to single-stranded DNA and
ADP. Cell 90, 635–647.
27. Bartenschlager, R., Ahlborn-Laake, L., Mous, J. & Jacobsen, H. (1994).
Kinetic and structural analyses of hepatitis C virus polyprotein
processing. J. Virol. 68, 5045–5055.
28. Walker, J.E., Saraste, M., Runswick, M.J. & Gay, N.J. (1982). Distantly
related sequences in the alpha- and beta-subunits of ATP synthase,
myosin, kinases and other ATP-requiring enzymes and a common
nucleotide binding fold. EMBO J. 1, 945–951.
29. Saraste, M., Sibbald, P.R. & Wittinghofer, A. (1990). The P-loop – a
common motif in ATP- and GTP-binding proteins. Trends Biochem.
Sci. 15, 430–434.
30. Raghunathan, S., Ricard, C.S., Lohman, T.M. & Waksman, G. (1997).
Crystal structure of the homo-tetrameric DNA-binding domain of
Escherichia coli single-stranded DNA-binding protein determined by
multiwavelength X-ray diffraction on the selenomethionyl protein at
2.9 Å resolution. Proc. Natl. Acad. Sci. USA 94, 6652–6657.
31. Ruff, M., et al., & Moras, D. (1991). Class II aminoacyl transfer RNA
synthetases: crystal structure of yeast aspartyl-tRNA synthetase
complexed with tRNA(Asp). Science 252, 1682–1689.
32. Bochkarev, A., Pfuetzner, R.A., Edwards, A.M. & Frappier, L. (1997).
Structure of the single-stranded-DNA-binding domain of replication
protein A bound to DNA. Nature 385, 176–181.
33. Kim, Y., Geiger, J.H., Hahn, S. & Sigler, P.B. (1993). Crystal structure
of a yeast TBP/TATA-box complex. Nature 365, 512–520.
34. Kim, J.L., Nikolov, D.B. & Burley, S.K. (1993). Co-crystal structure of
TBP recognizing the minor groove of a TATA element. Nature 365,
520–527.
35. George, J.W., Brosh, R.M., Jr. & Matson, S.W. (1994). A dominant
negative allele of the Escherichia coli uvrD gene encoding DNA
helicase II. A biochemical and genetic characterization. J. Mol. Biol.
235, 424–435.
36. Seeley, T.W. & Grossman, L. (1990). The role of Escherichia coli
UvrB in nucleotide excision repair. J. Biol. Chem. 265, 7158–7165.
37. Black, M.E. & Hruby, D.E. (1992). Site-directed mutagenesis of a
conserved domain in vaccinia virus thymidine kinase. Evidence for a
potential role in magnesium binding. J. Biol. Chem. 267, 6801–6806.
38. Yan, H.G. & Tsai, M.D. (1991). Mechanism of adenylate kinase.
Demonstration of a functional relationship between aspartate 93 and
Mg2+ by site-directed mutagenesis and proton, phosphorus-31, and
magnesium-25 NMR. Biochemistry 30, 5539–5546.
39. Gross, C.H. & Shuman, S. (1995). Mutational analysis of vaccinia virus
nucleoside triphosphate phosphohydrolase II, a DExH box RNA
helicase. J. Virol. 69, 4727–4736.
40. Brosh, R.M., Jr. & Matson, S.W. (1995). Mutations in motif II of
Escherichia coli DNA helicase II render the enzyme nonfunctional in
both mismatch repair and excision repair with differential effects on
the unwinding reaction. J. Bacteriol. 177, 5612–5621.
Research Article  Hepatitis C virus NS3 helicase domain Kim et al.    99
41. Pause, A. & Sonenberg, N. (1992). Mutational analysis of a DEAD box
RNA helicase: the mammalian translation initiation factor eIF-4A.
EMBO J. 11, 2643–2654.
42. Heilek, G.M. & Peterson, M.G. (1997). A point mutation abolishes the
helicase but not the nucleoside triphosphatase activity of hepatitis C
virus NS3 protein. J. Virol. 71, 6264–6266.
43. Gross, C.H. & Shuman, S. (1996). The QRxGRxGRxxxG motif of the
vaccinia virus DExH box RNA helicase NPH- II is required for ATP
hydrolysis and RNA unwinding but not for RNA binding. J. Virol. 70,
1706–1713.
44. Pause, A., Methot, N. & Sonenberg, N. (1993). The HRIGRXXR region
of the DEAD box RNA helicase eukaryotic translation initiation factor
4A is required for RNA binding and ATP hydrolysis. Mol. Cell Biol. 13,
6789–6798.
45. Hall, M.C. & Matson, S.W. (1997). Mutation of a highly conserved
arginine in motif IV of Escherichia coli DNA helicase II results in an
ATP-binding defect. J. Biol. Chem. 272, 18614–18620.
46. Bilderback, T., Fulmer, T., Mantulin, W.W. & Glaser, M. (1996).
Substrate binding causes movement in the ATP binding domain of
Escherichia coli adenylate kinase. Biochemistry 35, 6100–6106.
47. Schulz, G.E. (1992). Induced-fit movements in adenylate kinases.
Faraday Discuss. 93, 85–93.
48. Moore, K.J. & Lohman, T.M. (1994). Kinetic mechanism of adenine
nucleotide binding to and hydrolysis by the Escherichia coli Rep
monomer. 1. Use of fluorescent nucleotide analogues. Biochemistry
33, 14550–14564.
49. Chao, K. & Lohman, T.M. (1990). DNA and nucleotide-induced
conformational changes in the Escherichia coli Rep and helicase II
(UvrD) proteins. J. Biol. Chem. 265, 1067–1076.
50. Hakansson, K., Doherty, A.J., Shuman, S. & Wigley, D.B. (1997). X-ray
crystallography reveals a large conformational change during guanyl
transfer by mRNA capping enzymes. Cell 89, 545–553.
51. Subramanya, H.S., Doherty, A.J., Ashford, S.R. & Wigley, D.B. (1996).
Crystal structure of an ATP-dependent DNA ligase from
bacteriophage T7. Cell 85, 607–615.
52. Phillips, R.J., Hickleton, D.C., Boehmer, P.E. & Emmerson, P.T. (1997).
The RecB protein of Escherichia coli translocates along single-
stranded DNA in the 3′ to 5′ direction: a proposed ratchet
mechanism. Mol. Gen. Genet. 254, 319–329.
53. Ali, J.A. & Lohman, T.M. (1997). Kinetic measurement of the step size
of DNA unwinding by Escherichia coli UvrD helicase. Science 275,
377–380.
54. Chen, Y.Z., Zhuang, W. & Prohofsky, E.W. (1992). Energy flow
considerations and thermal fluctuational opening of DNA base pairs at
a replicating fork: unwinding consistent with observed replication
rates. J. Biomol. Struct. Dyn. 10, 415–427.
55. Wong, I. & Lohman, T.M. (1992). Allosteric effects of nucleotide
cofactors on Escherichia coli Rep helicase-DNA binding. Science
256, 350–355.
56. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S.M. & Rice, C.M.
(1993). Expression and identification of hepatitis C virus polyprotein
cleavage products. J. Virol. 67, 1385–1395.
57. Lin, C., Pragai, B.M., Grakoui, A., Xu, J. & Rice, C.M. (1994). Hepatitis
C virus NS3 serine proteinase: trans-cleavage requirements and
processing kinetics. J. Virol. 68, 8147–8157.
58. Warrener, P. & Collett, M.S. (1995). Pestivirus NS3 (p80) protein
possesses RNA helicase activity. J. Virol. 69, 1720–1726.
59. Furey, W. & Swaminathan, S. (1997). PHASES-95: a program
package for the processing and analysis of diffraction data from
macromolecules. Methods Enzymol. 277, 590–620.
60. Wang, B.C. (1985). Resolution of phase ambiguity in macromolecular
crystallography. Methods Enzymol. 115, 90–112.
61. Zhang, K.Y.J. & Main, P. (1990). The use of Sayre’s equation with
solvent flattening and histogram matching for phase extension and
refinement of protein structures. Acta Cryst. A 46, 377–381.
62. Project, C.C. (1994). The CCP4 suite: programs for protein
crystallography. Acta Cryst. D 50, 760–763.
63. Brünger, A.T. (1993). X-PLOR: A System for X-Ray Crystallography
and NMR. Yale University Press, New Haven, CT.
64. Brünger, A.T. (1992). Free R value: a novel statistical quantity for
assessing the accuracy of crystal structures. Nature 355, 472–475.
100 Structure 1998, Vol 6 No 1
